¡Ya estamos en ! Descubre más

Prestige Consumer Healthcare

PBH

Capitalización de mercado USD 2365 M

49.92 USD

+0.72

1.46%

Al cierre Actualizado 16 oct, 4:00 p.m. EDT

Antes de la apertura del mercado

Después del cierre del mercado

49.92

0.00

0%

1 día

1.46%

5 días

2.89%

1 mes

6.53%

3 meses

-1.34%

6 meses

-12.5%

En lo que va del año

-18.46%

1 año

-19.24%

5 años

-14.77%

10 años

6.21%

Acerca de: Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Empleados: 890

Atención médica Fabricantes de medicamentos especializados y genéricos

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 37.5%

Neutral 58.3%

Negativo 4.2%

Zacks Investment Research

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?

PBH's brand-building, acquisitions and e-commerce growth support fiscal 2027 revenue gains, but competition and currency risks remain key challenges.

Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now?

Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on Thursday, November 5, 2026 before the opening of the market.

Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results

Zacks Investment Research

Best Value Stocks to Buy for October 1st

BP and PBH made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 1, 2026.

Best Value Stocks to Buy for October 1st

Zacks Investment Research

PBH vs. NEOG: Which Stock Is the Better Value Option?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks?

PBH vs. NEOG: Which Stock Is the Better Value Option?

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds

While 63% say women are more comfortable discussing intimate wellness than five years ago, new research reveals a gap between cultural progress and personal comfort TARRYTOWN, N.Y., Sept. 30, 2026 /PRNewswire/ -- Women may be talking more openly about intimate health and wellness, but that does not necessarily mean the discomfort has disappeared.

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds

Zacks Investment Research

PBH or NEOG: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?

PBH or NEOG: Which Is the Better Value Stock Right Now?

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference

TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m.

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference

Zacks Investment Research

Is This the Right Time to Add PBH Stock to Your Portfolio?

Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.

Is This the Right Time to Add PBH Stock to Your Portfolio?

Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test

National survey commissioned by DenTek, the #1 OTC dental guard brand for nighttime teeth grinding, finds nearly 8 in 10 football fans keep thinking about the game after it ends, with many reporting stress-related behaviors that extend into bedtime. NFL legends Ronde & Tiki Barber join DenTek to encourage fans to recognize when football stress may be affecting more than just game day.

Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™